Skip to content

Effect of remimazolam on postoperative delirium in elderly patients undergoing abdominal surgery--a multicenter, randomized, controlled study

Effect of remimazolam on postoperative delirium in elderly patients undergoing abdominal surgery--a multicenter, randomized, controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120499
Enrollment
Unknown
Registered
2026-03-16
Start date
2026-03-16
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Sponsors

The First Affiliated Hospital of USTC (Anhui Provincial Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: Age 65~85 years; BMI 18-30kg/m^2, American Society of Anesthesiologists Physical Status ? or ?; NYHA cardiac functional class I-II; elective abdominal surgery (gastrointestinal, hepatobiliary, urinary system, gynecological surgery), estimated operation time 2 - 4 hours; MMSE score>18 points one day before surgery.

Exclusion criteria

Exclusion criteria: History of mental and neurological disorders (such as cerebrovascular disease, epilepsy, Alzheimer's disease, schizophrenia and depression, etc.), long-term oral sedation, anti-anxiety and other drugs; severe cardiovascular and cerebrovascular system diseases, severe respiratory system diseases, recent upper respiratory tract infection, severe lung function damage, severe liver and kidney dysfunction; recent history of drug use of remimazolam or propofol; allergy history and contraindications of related drugs; alcohol or drug abuse within 3 months; Surgery time 4 hours, unplanned transfer to ICU.

Design outcomes

Primary

MeasureTime frame
The onset time, frequency and duration of postoperative delirium.;

Secondary

MeasureTime frame
blood pressure;heart rate;SPO2;length of procedure;Duration of general anesthesia;postoperative extubation time;Duration of stay in PACU;Remifentanil dosage;Vasoactive drug dosage;

Countries

China

Contacts

Public ContactYanhu Xie

The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

xieyhsy@ustc.edu.cn+86 139 5601 3081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026